Cargando…
The difference between concealment and blinding in clinical trials and why both are important. A reply to Garg and Mickenautsch, BMC Medical Research Methodology (2022) 22:17
Autores principales: | Lyden, Patrick, Broderick, Joseph, Grotta, James, Kwiatkowski, Thomas, Levine, Steven, Frankel, Michael, Haley, E. Clarke, Tilley, Barbara |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664512/ https://www.ncbi.nlm.nih.gov/pubmed/37990152 http://dx.doi.org/10.1186/s12874-023-02074-5 |
Ejemplares similares
-
Reply to: Concerns about the Burden of Proof studies
por: Aravkin, Aleksandr Y., et al.
Publicado: (2023) -
Reply to: Revisiting the origin of octoploid strawberry
por: Edger, Patrick P., et al.
Publicado: (2019) -
Reply to: “Pitfalls in identifying active catalyst species”
por: Pereira-Hernández, Xavier Isidro, et al.
Publicado: (2020) -
Reply to “Points of view in understanding trilobite eyes”
por: Scholtz, Gerhard, et al.
Publicado: (2021) -
Reply to “A resurrection of the Haber-Weiss reaction”
por: Zhao, Yumeng, et al.
Publicado: (2022)